Supplemental iodide for preterm infants and developmental outcomes at 2 years: An RCT

Pediatrics

Volumn 139, Issue 5, 2017, Pages

  Williams, Fiona L R ^a   Ogston, Simon ^a   Hume, Robert ^a   Watson, Jennifer ^a   Stanbury, Kayleigh ^b   Willatts, Peter ^c   Boelen, Anita ^d   Juszczak, Edmund ^b   Brocklehurst, Peter ^e  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; PLACEBO; SODIUM CHLORIDE; SODIUM IODIDE; THYROGLOBULIN; THYROTROPIN; THYROXINE; IODIDE; THYROXINE BINDING GLOBULIN;

ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; CHILD; CHILD DEATH; CHILD DEVELOPMENT; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPOTHYROIDISM; INFANT; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEWBORN; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; BLOOD; BRAIN; DRUG EFFECTS; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PARENTERAL NUTRITION; PHYSIOLOGY;

BRAIN; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, PREMATURE; IODIDES; PARENTERAL NUTRITION; THYROTROPIN; THYROXINE; THYROXINE-BINDING GLOBULIN; TREATMENT OUTCOME;

EID: 85019021124     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-3703     Document Type: Article

References (36)

1. Williams FLR, Mires GJ, Barnett C, et al.; Scottish Preterm Thyroid Group. Transient hypothyroxinaemia in preterm infants: the role of cord sera thyroid hormone levels adjusted for prenatal and intrapartum factors. J Clin Endocrinol Metab. 2005;90(8):4599-4606
2. Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321(1):13-16
3. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med. 1991;324(8):532-536
4. Hume R, Simpson J, Delahunty C, et al.; Scottish Preterm Thyroid Group. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab. 2004;89(8):4097-4103
5. Pavelka S, Kopecky P, Bendlova B, et al. Tissue metabolism and plasma levels of thyroid hormones in critically ill very premature infants. Pediatr Res. 1997;42(6):812-818
6. Simpson J, Williams FLR, Delahunty C, et al.; Scottish Preterm Thyroid Group. Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J Clin Endocrinol Metab. 2005;90(3):1271-1279
7. Ares S, Escobar-Morreale HF, Quero J, et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab. 1997;82(6):1704-1712
8. Ibrahim M, de Escobar GM, Visser TJ, et al. Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(1):F56-F57
9. Agostoni C, Buonocore G, Carnielli VP, et al.; ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50(1):85-91
10. Greene HL, Hambidge KM, Schanler R, Tsang RC. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition. Am J Clin Nutr. 1988;48(5):1324-1342
11. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41(suppl 2):S1-S87
12. van den Hove MF, Beckers C, Devlieger H, de Zegher F, De Nayer P. Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatment. Biochimie. 1999;81(5):563-570
13. l'Allemand D, Gruters A, Beyer P, Weber B. Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res. 1987;28(1):42-49
14. Delgado MM, Rohatgi R, Khan S, Holzman IR, Satlin LM. Sodium and potassium clearances by the maturing kidney: clinical-molecular correlates. Pediatr Nephrol. 2003;18(8):759-767
15. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996;334(13):821-827
16. Lucas A, Rennie J, Baker BA, Morley R. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child. 1988;63(10):1201-1206
17. Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL. Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child. 1992;67(7):944-947
18. Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res. 1996;39(1):142-145
19. Simic N, Asztalos EV, Rovet J. Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth. Thyroid. 2009;19(4):395-401
20. Delahunty C, Falconer S, Hume R, et al.; Scottish Preterm Thyroid Group. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. J Clin Endocrinol Metab. 2010;95(11):4898-4908
21. Williams F, Hume R, Ogston S, Brocklehurst P, Morgan K, Juszczak E; I2S2 Team. A summary of the iodine supplementation study protocol (I2S2): a UK multicentre randomised controlled trial in preterm infants. Neonatology. 2014;105(4):282-289
22. Bayley N. Bayley Scales of Infant and Toddler Development (Bayley-III). 3rd ed. San Antonio, TX: Pearson; 2005
23. van Wassenaer AG, Kok JH, de Vijlder JJM, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med. 1997;336(1):21-26
24. La Gamma EF, van Wassenaer AG, Ares S, et al. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics. 2009;124(2). Available at: www. pediatrics. org/cgi/content/full/124/2/e258
25. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJM, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics. 2001;107(4):712-718
26. van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics. 2005;116(5). Available at: www. pediatrics. org/cgi/content/full/116/5/e613
27. Linn M, Yoder BA, Clark RH. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation. Am J Perinatol. 2010;27(9):731-735
28. van Wassenaer-Leemhuis A, Ares S, Golombek S, et al. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid. 2014;24(7):1162-1169
29. Hume R, Lang K, Williams FLR. Iodine content of standard formula and specialized enteral preparations. In: Preedy VR, Burrow GN, Watson RR, eds. Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects. Cambridge, MA: Academic Press; 2009
30. Vanderpump MPJ, Lazarus JH, Smyth PP, et al.; British Thyroid Association UK Iodine Survey Group. Iodine status of UK schoolgirls: a cross-sectional survey. Lancet. 2011;377(9782):2007-2012
31. Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet. 2013;382(9889):331-337
32. Ahmet A, Lawson ML, Babyn P, Tricco AC. Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatr. 2009;98(10):1568-1574
33. Belfort MB, Pearce EN, Braverman LE, He X, Brown RS. Low iodine content in the diets of hospitalized preterm infants. J Clin Endocrinol Metab. 2012;97(4):E632-E636
34. Dold S, Zimmermann MB, Baumgartner J, et al. A dose-response crossover iodine balance study to determine iodine requirements in early infancy. Am J Clin Nutr. 2016;104(3):620-628
35. Willoughby KA, McAndrews MP, Rovet J. Effects of early thyroid hormone deficiency on children's autobiographical memory performance. J Int Neuropsychol Soc. 2013;19(4):419-429
36. Williams F, Hume R. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem. 2011;48(pt 1):7-22